Merck & Co

Aurinia's Lupkynis for Lupus; Toripalimab; Merck’s Covid-19 Vaccines fail

Jan 26, 2021

Aurinia’s Lupkynis for Lupus; FDA Fast Track Designation for Toripalimab; Wren Therapeutics’ Financing; Merck’s Covid-19 Vaccine Program End

Latest COVID-19/ SARS-CoV-2 news

Apr 28, 2020

In the race to fight SARS-CoV-2: Merck, ISB; ViiV; Genalyte gears up

Anaphylaxis

Jan 10, 2020

Anaphylaxis: A Rare Disease

Oct 09, 2018

Notizia

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper